Share Name Share Symbol Market Type Share ISIN Share Description
Hutchison China Meditech LSE:HCM London Ordinary Share KYG4672N1016 ORD USD1
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -70.00p -1.25% 5,540.00p 5,500.00p 5,580.00p 5,620.00p 5,520.00p 5,610.00p 13,571 15:08:35
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 175.0 -38.3 16.2 384.9 3,365.56

Hutchison China Meditech Share Discussion Threads

Showing 1301 to 1325 of 1325 messages
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older
DateSubjectAuthorDiscuss
11/1/2018
09:11
Thanks Nerdofsteel. I think that's fair comment.
reptile3
11/1/2018
07:28
6 months ago I would say it could have a dramatically positive impact but with the recent uplift driven by the NASDAQ market I would now say it’s largely priced in, but we may still get a surprise. There are plenty of other material events coming shortly too...
nerdofsteel
10/1/2018
16:32
I don't want to lower the tone of the thread which is exemplary in my opinion but does anyone have any idea what effect Chinese government approval of the licence would have on the share price?
reptile3
10/1/2018
11:45
Thanks Nerd. I watched the Panmure CEO interview again at the weekend. Mr Hogg certainly comes across as an impressive individual.
melf
10/1/2018
09:05
Nothing new but here's a nice new summary article from a U.S. Specialist Biotech IR Firm from yesterday..... hxxp://www.biotuesdays.com/features/2018/1/8/chi-med-transforming-into-fully-integrated-pharma
nerdofsteel
04/1/2018
14:31
Well spotted. Thank you Nerdo.
scanjet17
04/1/2018
12:03
Nice article in yesterday's WSJ which has plenty of coverage of Chi-Med hxxps://mobile.nytimes.com/2018/01/03/business/china-drugs-health-care.html?smid=tw-nytimesbusiness&smtyp=cur&referer=hxxps://t.co/SbvWxbww5U?amp=1
nerdofsteel
03/1/2018
07:19
The American specialist Investors finally get what the Company is about and the huge prospects for the late stage pipeline. A brilliant company with a fantastic management team who always deliver....
nerdofsteel
02/1/2018
17:41
Up 5% in New York!
spittingbarrel
02/1/2018
07:33
Good points about Tagrisso Mitzi thank you. I wonder where we are with regards to Breakthrough Therapy designation....that would really set things alight..
nerdofsteel
01/1/2018
14:23
As both of us know , Tagrisso fails in phase 3 in 30% of NSCLC cases cos of Cmet .If azn, as seems likely, choose to go to phase 3 with Savolitinib to solve that problem and it proves successful , £250 quid will eventually come . Tagrisso has now been approved for phase 1, let alone phase 3 , so the numbers could be staggering let alone for all other indications where savolitinib can be used. Anyhow let's see how it plays out .
miti 1000
31/12/2017
16:25
miti - good call, we also have Eli Lilly's last chance to decide if they want to take up global rights to Fruquintinib, and if they do they'll have to make a big lump sum payment which will radicalley alter our 2018 numbers. This will be a $20bn mcap company in the next 5 years IMO My 2017 share price target of £52ish has been trounced completely! My 2018 calendar year end proce target is £61 but there's every chance that could be hit in January.....clearly I need to re-visit my valuationm model....£250 by 2026
nerdofsteel
29/12/2017
17:30
Well it's hit $40 across the pond. Those mid twenties director buys a few months ago are looking pretty nice now :-)
melf
29/12/2017
16:01
At 3:53 UK time share price on NASDAQ = $39.86. Times 2 = $79.72 which equals £59.30. Another all time high. I agree that £100 next year looks very possible. A happy, healthy and prosperous new year to all.
reptile3
29/12/2017
10:43
So, £100 next year? Since I bought in July I'm up over 50%. Happy new year to all!
mad foetus
29/12/2017
09:32
Nice rise again today but still cheaper than the ADRs.
spittingbarrel
28/12/2017
11:52
Big news due in January, AZN decision on savolitinib for phase 3 and the China drug approval for fruquintinib.
miti 1000
28/12/2017
10:21
All time high just reached in London, a vote of confidence as we head into 2018!
nerdofsteel
26/12/2017
09:20
Merry xmas all! Another great year ahead which will include our first drug approval in China and possible Breakthrough Therapy designation in the U.S.
nerdofsteel
22/12/2017
21:46
Yep...just seen that, should be a big rise Monday. Feel like the momentum is building and many of the circumstantial barriers are being broken down. Think that China support for US sanctions against N Korea will bring the two together and HCM will be a big benefactor.
rabiddog
22/12/2017
17:25
And with HCM hitting an all time high in the US, happy Christmas to all!
mad foetus
22/12/2017
09:44
Thanks for posting the article Nerd. Season's greetings to you and all holders.
melf
21/12/2017
16:24
another great article on Chi-Med posted today on Seeking Alpha https://seekingalpha.com/article/4133199-hutchison-china-meditech-outlook-2018?app=1&auth_param=1dk0ei:1d3neeu:02976233daa15453b007ec873b604b04&uprof=45&dr=1
nerdofsteel
14/12/2017
07:04
Huge amounts of news due including next property compensation payment
nerdofsteel
12/12/2017
13:55
The long term support line for HCM on the NASDAQ is around $30 to $31 so we are either at, or very close to, the end of this reversal...... IMO.
reptile3
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180119 15:45:53